Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Government of Canada was posted on May 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Acquisition d'un isolateur pour le Centre d'excellence en thérapie cellulaire

Closed
20136806International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334510
New
Federal
6515--ForeSite SS Tablet w/Pressure Mapping Sensor System
Solicitation # 36C24827Q0082
The Department of Veterans Affairs, through Network Contracting Office 8, is conducting market research via a Sources Sought Notice to identify authorized sources for the ForeSite SS Tablet Pressure Mapping System manufactured by ForeSite Medical. This effort is for acquisition planning purposes and is not a formal solicitation. The required system is intended for clinical pressure assessment and treatment and must include the tablet platform, pressure-mapping sensors, sensor packs, chargers, software licenses, cables, and all necessary accessories. Key functional requirements include real-time pressure analysis and visualization, patient data storage and reporting, wireless and wired connectivity, and portable battery-powered operation. All equipment must be new and include the manufacturer's standard warranty. Interested vendors must submit electronic responses in PDF or Word format by October 30, 2026. Submissions must include the company name, address, Unique Entity Identifier, point of contact, and business size or socioeconomic status, such as SDVOSB, VOSB, Small Business, or Large Business. Additionally, respondents must provide documentation proving they are authorized to distribute or resell the ForeSite system, an estimated delivery lead time, and confirmation regarding the new condition and warranty of the product. The place of performance is located in Tampa, Florida, under NAICS code 334510.
248-NETWORK Contract Office 8 (36C248)

POSTED

about 15 hours ago

DEADLINE

in 2 days
NAICS: 334510
New
Federal
Electro-Therapeutic Modalities for Pain Management (ETMPM) - Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program
Solicitation # 36C79126R0011
The Department of Veterans Affairs is soliciting proposals under Solicitation Number 36C79126R0011 to establish multiple single-award, Firm-Fixed-Price, Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for the Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program. This national program provides FDA-cleared electro-therapeutic devices and accessories to support non-opioid pain management across 168 VA Medical Centers and over 1,000 Community Based Outpatient Clinics. The scope includes portable TENS units, Interferential Current (IFC) devices, thermal and non-thermal Short-Wave Diathermy (SWD) devices, and portable neuromodulation systems for headache disorders, along with associated consumables such as electrodes, lead wires, and chargers. The procurement utilizes a VA Tiered Set-Aside Evaluation Approach, prioritizing Service-Disabled Veteran-Owned Small Businesses (Tier 1), followed by Veteran-Owned Small Businesses (Tier 2), other small business concerns (Tier 3), and finally other-than-small business concerns (Tier 4). Award methodology varies by item: CLINs X001 through X004 are evaluated based on Lowest Price Technically Acceptable (LPTA) procedures, while CLIN X005 is evaluated using a Best Value Tradeoff method, weighting technical factors at 60 percent, price at 25 percent, and past performance at 15 percent. Responsive proposals must include a signed SF 1449, a Technical Capability Statement, FDA 510(k) clearance letters, and three recent past performance documents. Non-manufacturers must provide OEM-issued Authorized Distributor Letters. Mandatory certifications include the Price Matrix, Limitations on Subcontracting, and either the Buy American Certificate (for small businesses) or the Trade Agreements Certificate (for large businesses). Product samples for every offered item must be shipped to the Denver Logistics Service facility. Following several amendments, the final deadline for the receipt of all proposal documentation and product samples is November 2, 2026, at 12:00 PM CDT.
Commodities & Services Acquisition Service (36C791)

POSTED

1 day ago

DEADLINE

in 6 days
NAICS: 334510
New
Federal
Scanner Ultrasonic Ocular
Solicitation # W91CRB-26-AWSP-Scanner-Ultrasonic-Ocular-RPP
The Portfolio Acquisition Executive Maneuver Ground, Project Manager Maneuver Medical Systems is soliciting prototype proposals for Scanner Ultrasonic Ocular devices under Other Transaction Authority pursuant to 10 U.S.C. 4022. The objective is to identify and award two prototype agreements to procure FDA-approved commercial off-the-shelf or non-developmental item solutions that require minimal to no modification. Selected awardees must deliver four prototype devices for operational and environmental testing, including ruggedized transport cases meeting MIL-STD-810H standards. The estimated period of performance is twelve months, with awards expected in FY27 Q1 and prototype delivery required within 45 to 60 days after award. This procurement is not a FAR-based solicitation and utilizes a comparative best-fit methodology for award, prioritizing technical approach, maturity, performance compliance, reliability, schedule realism, and past performance over cost. Proposals must be submitted in four volumes by November 3, 2026, and include a Trade Agreements Act certificate and SAM.gov registration. Technical requirements include compliance with Critical Operational Device Specifications for ocular trauma imaging and adherence to NIST SP 800-171 for handling Controlled Unclassified Information. The system must operate as a standalone device without connecting to Department of War networks.
W6QK Acc-Apg

POSTED

1 day ago

DEADLINE

in 16 days

AI Contract Overview

Show more

Santé Québec, par l’entremise du Centre intégré universitaire de santé et de services sociaux de l’Est-de-l’Île-de-Montréal, cherche à acquérir un seul isolateur destiné au Centre d’excellence en thérapie cellulaire afin de remplir les exigences strictes de stérilité pour le remplissage final de produits injectables tels que les vecteurs viraux. Cet équipement doit permettre la création d’un environnement de classe A et garantir la protection des opérateurs lors de la manipulation d’agents de biosécurité niveau II. L’isolateur comprend une chambre principale munie de quatre gants, deux sas, un testeur d’étanchéité des gants, des rallonges, un panneau de commande intégré, des raccordements pour les utilités, un système de décontamination au peroxyde d’hydrogène, un filtre HEPA et un capteur indépendant de surveillance du H₂O₂ dans la pièce. Les soumissions doivent être déposées au Bureau LA-505-19, 5e étage, pavillon Lahaise de l’Institut universitaire en santé mentale de Montréal, à l’adresse précisée, avec une attention particulière à l’exactitude de l’adresse pour les envois par messagerie. Une visite des lieux est obligatoire et prévue le 17 avril 2026 à 10 heures à l’entrée de l’hôpital Maisonneuve-Rosemont. Les documents d’appel d’offres sont exclusivement accessibles via le système électronique d’appel d’offres, et la soumission doit être reçue avant le 15 mai 2026 à 19 heures. L’organisme ne s’engage pas à accepter toute soumission reçue.

General Info

Acquisition d’un isolateur stérile pour thérapie cellulaire avec décontamination par H₂O₂ et classe A, soumission avant 15 mai 2026.

Agency

Government of Canada → Santé Québec - Établissement CIUSSS de l’Est-de-l’Île-de-Montréal

Place of Performance

Montréal, CAN

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Santé Québec - Établissement CIUSSS de l’Est-de-l’Île-de-Montréal
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Santé Québec - Établissement CIUSSS de l’Est-de-l’Île-de-Montréal
Office AddressN/A
Contacts
Masse-Leblanc SophieContracting Authority

Full Description

Show more
Santé Québec, agissant par l’entremise de son établissement le Centre intégré universitaire de santé et de services sociaux de l'Est-de-l’Île-de-Montréal (Santé Québec - CIUSSS-EMTL) désire faire l’acquisition d’UN (1) isolateur pour le Centre d’excellence en thérapie cellulaire (CETC) incluant les Services d’entretien afin de répondre aux besoins de sa clientèle. L'Équipement est utilisé pour créer un environnement de classe A pour l'opération de remplissage final de produits stériles injectables, par exemple des vecteurs viraux. Il est également utilisé pour toute opération exigeant la stérilité du produit ou la protection de l'opérateur lors de la manipulation d'agents de niveau de biosécurité II (BSL-II). L’Équipement comprend une chambre principale à QUATRE (4) gants avec DEUX (2) sas, un testeur d'étanchéité des gants, des rallonges de gants, un panneau de commande avec micrologiciel, des raccordements pour les utilités, un système de décontamination au peroxyde d'hydrogène (H₂O₂), un filtre à haute efficacité pour les particules de l’air (HEPA) et un capteur indépendant de surveillance du H₂O₂ dans la pièce. Dépôt des soumissions Institut universitaire en santé mentale de Montréal Pavillon Lahaise, 5e étage, aile 505 : Bureau LA-505-19 7401, rue Hochelaga Montréal (Québec) H1N 3M5 IMPORTANT : Le SOUMISSIONNAIRE qui utilise un service de messagerie pour expédier sa Soumission doit s’assurer que l’envoi soit livré à l’adresse exacte mentionnée ci-dessus. L’organisme public ne s’engage à accepter aucune des soumissions reçues. Les documents d’appel d’offres ne peuvent être obtenus que par l’intermédiaire du système électronique d’appel d’offres. Une visite des lieux est prévue : Date : 17 avril 2026 Heure : 10:00 Lieu : Hôpital Maisonneuve-Rosemont Centre d’excellence en thérapie cellulaire (CETC) Point de rencontre à l’entrée de l'Hôpital 5415, boulevard de l'Assomption Montréal (Québec) H1T 2M4

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS